Viant Technology, Inc. Class A DSP 深 沪
交易中 05-14 11:21:19 美东时间
10.55
+0.070
+0.67%
华盛通- 最 高10.55
- 今 开10.54
- 成交量 3.41万股
- 最 低 10.11
- 昨 收 10.48
- 总市值 6.73亿
- 52周最高 15.18
- 市盈率 静 78.50
- 换手率 0.05%
- 52周最低 8.11
- 委 比 -50.94%
- 总股本 6383.04万
- 历史最高 69.16
- 量 比 0.33
- 振 幅 4.20%
- 历史最低 3.15
- 每 手 1
- 风险率 1.84%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多电话会总结 ｜ Viant(DSP)2026财年Q1业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Viant业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **Q1 2026核心财务指标表现：** - **营收**：8,850万美元，同比增长25%，超出指导预期上限3% - **Contribution ex-TAC**：5,030万美元，同比增长18%，高于指导预期中位数 - **调整后EBITDA**：980万美元，同比增长81%，超出指导预期上限3% - **Non-GAAP净利润**：560万美元，同比增长近100%（去年同期280万美元） - **Non-GAAP每股收益**：0.09美元，同比增长125%（去年同期0.
05-13 12:28
美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
B. Riley Securities Maintains Buy on Viant Technology, Raises Price Target to $18
B. Riley Securities analyst Zach Cummins maintains Viant Technology (NASDAQ:DSP) with a Buy and raises the price target from $17 to $18.
05-12 23:49
Earnings Scheduled For May 11, 2026
Companies Reporting Before The Bell • United Parks & Resorts (NYSE:PRKS) is...
05-11 19:11
Sotera Health names new CEO in planned leadership transition
Sotera Health (SHC) on Tuesday said it appointed Alton Shader as CEO, effective May 26, as part of a planned leadership transition. Shader, currently CEO of Viant Medical, will also join the company’s...
05-05 20:18
Sotera Health Appoints Alton Shader As CEO, Effective May 26, Succeeding Michael Petras, Who Will Serve As Executive Chairman
Alton Shader, CEO of Viant Medical®, to become CEO and join the Board of Directors, effective May 26, 2026Chairman and CEO Michael B. Petras, Jr. will serve as Executive Chairman of the Board of DirectorsCLEVELAND,
05-05 19:25
Sotera Health Announces Leadership Transition
Sotera Health Company announced that Alton Shader, CEO of Viant Medical, will become its CEO and join the Board of Directors effective May 26, 2026. Michael B. Petras, Jr., the current Chairman and CEO, will serve as Executive Chairman to ensure a smooth leadership transition. Shader brings over 20 years of experience in the healthcare industry, having led Viant Medical through significant growth and expansion. Petras, who has served as CEO since...
05-05 11:00
Viant CFO Larry Madden sells 39,328 shares for $421,933
Viant CFO Larry Madden sells 39,328 shares for $421,933 Viant Technology CFO Larry Madden sold 39,328 Class A common shares on April 21-23. Sales prices averaged USD 10.16 to USD 10.91 per share. Madden’s direct holdings fell to 553,699 shares following transactions. Disclaimer: This news brief was
04-24 09:03
美股大行评级 | 美国银行、摩根士丹利、JB亨特运输服务、PNC金融服务、Cheniere Energy等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持FibroBiologics"买入"评级，目标价从4美元升至8美元；摩根士丹利：维持Ultragenyx药业"超配"评级，目标价从50美元升至67美元
04-17 11:27
DA Davidson Maintains Buy on Viant Technology, Raises Price Target to $16
DA Davidson analyst Tom White maintains Viant Technology (NASDAQ:DSP) with a Buy and raises the price target from $15.5 to $16.
04-17 00:03
